We are a rapidly growing, Boston-based medical technology company using AI to enable clinicians to make informed decisions on cardiovascular care - leading to better patient outcomes, improved quality of care, and reduced healthcare costs. Come work at Elucid and be part of delivering on our mission to prevent heart attacks and strokes!
The product team at Elucid excels at balancing technical constraints and business goals to deliver customer-centric and compliant products that advance cardiovascular care. Our Product Owners clarify product vision and drive development priorities within our agile teams, steering initiatives from initial concept through successful launch. Their technical background in medical imaging and ability to build strong cross-functional relationships enable collaboration with engineers to scope features and partner across sales, marketing, and product teams to ensure everything we build delivers real value to physicians and their patients.
The ideal candidate will have:- Experience managing software development projects with a strong understanding of modern, agile methodologies in development and deployment.
- 3+ years of experience as a Product Owner, preferably working with MedTech and Medical Imaging. AI/ML products experience is a plus.
- Excellent communication and interpersonal skills to effectively collaborate with cross-functional teams and stakeholders.
- Ability to condense highly complex technical topics into concise, clear direction in both written and verbal communications.
- Analytical mindset and data-driven decision-making skills.
- Ability to thrive in a fast-paced, dynamic startup environment, and comfortability with changing priorities and ambiguity.
- This is a role based out of our office in Boston, MA. Our team operates in a hybrid model and has a preference for local candidates or those located in eastern time zones in the continental U.S.
Travel Requirements
- Occasional travel may be required.
Similar Jobs
What We Do
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe







